
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : AdCOVID
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Altimmune
Deal Size : Undisclosed
Deal Type : Agreement
Details : Altimmune has entered into an agreement with Vigene Biosciences to manufacture AdCOVID, Altimmune’s single-dose intranasal vaccine candidate for COVID-19.
Product Name : AdCOVID
Product Type : Vaccine
Upfront Cash : Undisclosed
July 22, 2020
Lead Product(s) : AdCOVID
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Altimmune
Deal Size : Undisclosed
Deal Type : Agreement

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Genetic Disease
Study Phase : Undisclosed
Sponsor : ASC Therapeutics
Deal Size : Undisclosed
Deal Type : Partnership
Details : Vigene will provide ASC with access to GMP mfg including viral vectors and plasmid DNA for its Hemophilia A gene therapy clinical program, as well as a manufacturing platform for future programs.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
January 14, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Genetic Disease
Highest Development Status : Undisclosed
Sponsor : ASC Therapeutics
Deal Size : Undisclosed
Deal Type : Partnership
